Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
10/2003
10/07/2003US6630496 Inhibitors of phospholipase enzymes
10/07/2003US6630479 Methods and compositions utilizing quinazolinones
10/07/2003US6630469 5-HT7 receptor antagonists
10/07/2003US6630468 Disubstituted pyrazolines and triazolines as factor Xa inhibitors
10/07/2003US6630463 Heterocycle-containing carboxylic acid derivative and drug containing the same
10/07/2003CA2270026C Substituted bicyclic derivatives for treating central nervous system disorders
10/07/2003CA2263957C Diarylmethyl piperazine derivatives as delta opioid agonists
10/02/2003WO2003080760A1 Material for organic electroluminescent devices and organic electroluminescent devices made by using the same
10/02/2003WO2003080697A1 Low-viscosity polyisocyanate composition having high functionality and method for preparing same
10/02/2003WO2003080598A1 Deuterated substituted indoles and medicaments containing said compounds
10/02/2003WO2003080582A2 Fredericamycin derivatives
10/02/2003WO2003080577A2 Amidoacetonitrile compounds
10/02/2003WO2003080545A2 Substituted phenylacetic acids
10/02/2003WO2003080543A1 Process for producing cyclic compound
10/02/2003WO2003080184A1 1,2-dihydropyrazol-3-ones as cytokine mediators
10/02/2003WO2003080125A2 Benzimidazoles and their use as mitogen-activated- and rho-kinase inhibitors
10/02/2003WO2003080058A1 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/02/2003WO2003079973A2 Mitotic kinesin inhibitors
10/02/2003WO2003045912A8 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
10/02/2003WO2003042173A8 Nk1 antagonists
10/02/2003WO2003039529A8 Selective antibacterial agents
10/02/2003US20030187275 Diagnosis, therapy tumors
10/02/2003US20030187268 Imidazole derivatives
10/02/2003US20030187053 Eating disorders; antilipemic agents; anticholesterol agents; cardiovascular disorders
10/02/2003US20030187051 Anticholesterol agents, cardiovascular disorders, hypotensive agents, antidiabetic agents, antitumor agents
10/02/2003US20030187026 Antiproliferative agents
10/02/2003US20030187024 Vision disorders; antiinflammatory agents; autoimmune disease; anticancer qgents; skin disorders
10/02/2003US20030187007 Inhibitors of protein kinase for the treatment of disease
10/02/2003US20030187002 Antiproliferative agents; anticancer agents
10/02/2003US20030186995 Substituted bicyclic derivatives useful as anticancer agents
10/02/2003US20030186990 Prodrugs of hiv replication inhibiting pyrimidines
10/02/2003US20030186969 Benzodiazepine derivatives
10/02/2003US20030186961 Central nervous system disorders; vision defects
10/02/2003US20030186958 Viricides, vision defects, oral diseases, antiarthritic agents, multiple sclerosis, anticancer agents
10/02/2003CA2761440A1 Fredericamycin derivatives
10/02/2003CA2479338A1 Substituted phenylacetic acids
10/02/2003CA2477091A1 1,2-dihydropyrazol-3-ones as cytokine mediators
10/01/2003EP1348695A1 Derivatives of paraphenylene diamine with pyrrolidine groups substituted by cationic radicals and their use for dyeing keratinic fibre
10/01/2003EP1347967A1 Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists
10/01/2003EP1347959A1 Indole derivatives as ligands of thyroid receptors
10/01/2003EP1347957A1 Delta 1-pyrrolines used as pesticides
10/01/2003EP1347955A1 New mandelic acid derivatives and their use as throbin inhibitors
10/01/2003EP1071665B1 Substituted indolinones having an inhibiting effect on kinases and cycline/cdk complexes
10/01/2003CN1446214A Cinnoline compounds
10/01/2003CN1446213A Medicinal compositions containing propenone derivatives
10/01/2003CN1445226A New cornpound derivated from quinazoline, itd preparation method and medicinal composite containig them
10/01/2003CN1122533C Pigment labelled protein composite and its preparing method
10/01/2003CN1122532C Pigment marked protein composite and its preparing method
09/2003
09/30/2003US6627649 (2S)-1-((2R,3S)-5-chloro-3-(2-chlorophenyl)-1-(3,4 -dimethoxybenzenesulfonyl)-3-hydroxy-2,3-dihydro-1H-indole-2 -carbonyl)pyrrolidine-2-carboxamide, a selective V1a arginine vasopressin receptor antagonist, in combination with the
09/30/2003US6627643 Sodium-hydrogen exchanger type 1 (NHE-1) inhibitors of formula I' are useful for the prevention and treatment of myocardial ischemic injury. Myocardial ischemic injury can occur in out-patient in perioperative settings and can lead to sudden
09/30/2003US6627627 Aralkyl and aralkylidene heterocyclic lactams and imides
09/30/2003US6627626 Antiinflammation agents and antiarthritic agents colon cancer, and Alzheimer's disease in mammals, preferably humans, dogs, cats and livestock animals.
09/25/2003WO2003078541A1 Material for organic electroluminescent devices and organic electroluminescent devices made by using the same
09/25/2003WO2003078423A1 Compositions useful as inhibitors of protein kinases
09/25/2003WO2003078404A1 Pyrimidine derivatives
09/25/2003WO2003078402A1 Indazoles substituted with an anti-cancerous activity
09/25/2003WO2003078398A1 NON-PEPTIDE GnRH ANTAGONISTS
09/25/2003WO2003078394A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators
09/25/2003WO2003078376A1 Nk1 antagonists
09/25/2003WO2003077921A1 Azinylaminoazoles as inhibitors of protein kinases
09/25/2003WO2003077914A1 N3 alkylated benzimidazole derivatives as mek inhibitors
09/25/2003WO2003077910A1 Methods of treatment with selective ep4 receptor agonists
09/25/2003WO2003077908A1 Use of selective ep4 receptor agonists for the treatment of liver failure, loss of patency of the ductus arteriosus, glaucoma or ocular hypertension
09/25/2003WO2003077907A1 Azetidine derivatives as ccr-3 receptor antagonists
09/25/2003WO2003077855A2 N3 alkylated benzimidazole derivatives as mek inhibitors
09/25/2003WO2003077656A1 4-aminopyrimidines and their use for the antimicrobial treatment of surfaces
09/25/2003WO2003011855A3 Pyrazole-derived kinase inhibitors and uses thereof
09/25/2003WO2002060392A3 Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
09/25/2003WO2002024690A3 Efficient process for the preparation of a factor xa inhibitor
09/25/2003US20030181730 Treating an alpha-2 adrenergic receptor associated disorder, useful as analgesic, sedative or anaesthetic agents
09/25/2003US20030181720 Chemical intermediate for making fungicides; debromination, hydroxylation, formation/c-c/
09/25/2003US20030181716 Novel azepane derivatives
09/25/2003US20030181499 For use as anti-human immunodeficiency virus (HIV) drugs
09/25/2003US20030181496 Having Transforming Growth Factor- beta inhibitory activity and being useful as fibrosis inhibitors for organs or tissues
09/25/2003US20030181482 Antitumor agents, anticarcinogenic agents, a 3-oxoacetamideindolyl compounds, for treating cancer, cytotoxic, and angiogensis inhibitors
09/25/2003US20030181481 Therapeutic drugs for treating central nervous system disorders
09/25/2003US20030181474 2,4-Di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents
09/25/2003US20030181465 Pyrimidines as novel openers of potassium ion channels
09/25/2003US20030181454 Nitrogen compounds and prodrugs used as type-II secretory phospholipase(sPLA2) agonists or antagonists, for prevention cancer, cirrhosis, Alzheimer's disease and/or arteriosclerosis
09/25/2003US20030180383 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents
09/25/2003CA2479266A1 Azetidine derivatives as ccr-3 receptor antagonists
09/25/2003CA2479222A1 Use of selective ep4 receptor agonists for the treatment of liver failure, loss of patency of the ductus arteriosus, glaucoma or ocular hypertension
09/25/2003CA2478713A1 Non-peptide gnrh antagonists
09/25/2003CA2478653A1 Methods of treatment with selective ep4 receptor agonists
09/25/2003CA2478540A1 Indazoles substituted with an anti-cancerous activity
09/25/2003CA2478534A1 N3 alkylated benzimidazole derivatives as mek inhibitors
09/25/2003CA2478211A1 Nk1 antagonists
09/25/2003CA2478172A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators
09/24/2003EP1346992A1 Quinazoline derivatives, process for their preparation and pharmaceutical compositions containing them
09/24/2003EP1346982A1 Vla-4 inhibitors
09/24/2003EP1345929A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345928A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345927A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345926A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345925A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345923A1 Azinyl sulfonylimidazoles for use as microbicidal agents
09/24/2003EP1345922A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345921A1 3-indoline derivatives useful in the treatment of psychiatric and neurologic disorders
09/24/2003EP1345920A1 Novel sulfamides and their use as endothelin receptor antagonists
09/24/2003EP1345909A1 Phenylacetamido-pyrazole derivatives and their use as antitumor agents
1 ... 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 ... 626